Cargando…
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally, and the number is still increasing rapidly. Herein, we present four critically ill patients with SARS-CoV-2 infection who received su...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195335/ https://www.ncbi.nlm.nih.gov/pubmed/32243945 http://dx.doi.org/10.1016/j.chest.2020.03.039 |
_version_ | 1783528511638601728 |
---|---|
author | Zhang, Bin Liu, Shuyi Tan, Tan Huang, Wenhui Dong, Yuhao Chen, Luyan Chen, Qiuying Zhang, Lu Zhong, Qingyang Zhang, Xiaoping Zou, Yujian Zhang, Shuixing |
author_facet | Zhang, Bin Liu, Shuyi Tan, Tan Huang, Wenhui Dong, Yuhao Chen, Luyan Chen, Qiuying Zhang, Lu Zhong, Qingyang Zhang, Xiaoping Zou, Yujian Zhang, Shuixing |
author_sort | Zhang, Bin |
collection | PubMed |
description | As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally, and the number is still increasing rapidly. Herein, we present four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy. |
format | Online Article Text |
id | pubmed-7195335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71953352020-05-02 Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Zhang, Bin Liu, Shuyi Tan, Tan Huang, Wenhui Dong, Yuhao Chen, Luyan Chen, Qiuying Zhang, Lu Zhong, Qingyang Zhang, Xiaoping Zou, Yujian Zhang, Shuixing Chest Article As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally, and the number is still increasing rapidly. Herein, we present four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy. The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians. 2020-07 2020-03-31 /pmc/articles/PMC7195335/ /pubmed/32243945 http://dx.doi.org/10.1016/j.chest.2020.03.039 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Zhang, Bin Liu, Shuyi Tan, Tan Huang, Wenhui Dong, Yuhao Chen, Luyan Chen, Qiuying Zhang, Lu Zhong, Qingyang Zhang, Xiaoping Zou, Yujian Zhang, Shuixing Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
title | Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
title_full | Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
title_fullStr | Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
title_full_unstemmed | Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
title_short | Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
title_sort | treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195335/ https://www.ncbi.nlm.nih.gov/pubmed/32243945 http://dx.doi.org/10.1016/j.chest.2020.03.039 |
work_keys_str_mv | AT zhangbin treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT liushuyi treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT tantan treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT huangwenhui treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT dongyuhao treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT chenluyan treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT chenqiuying treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT zhanglu treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT zhongqingyang treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT zhangxiaoping treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT zouyujian treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection AT zhangshuixing treatmentwithconvalescentplasmaforcriticallyillpatientswithsevereacuterespiratorysyndromecoronavirus2infection |